Related references
Note: Only part of the references are listed.Kinetics and MR-Based Monitoring of AAV9 Vector Delivery into Cerebrospinal Fluid of Nonhuman Primates
Kousaku Ohno et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Extensive Transduction and Enhanced Spread of a Modified AAV2 Capsid in the Non-human Primate CNS
Jerusha Naidoo et al.
MOLECULAR THERAPY (2018)
Sphingomyelin-induced inhibition of the plasma membrane calcium ATPase causes neurodegeneration in type A Niemann-Pick disease
A. Perez-Canamas et al.
MOLECULAR PSYCHIATRY (2017)
The Paravascular Pathway for Brain Waste Clearance: Current Understanding, Significance and Controversy
Andrew Bacyinski et al.
FRONTIERS IN NEUROANATOMY (2017)
Quantitative imaging of tissue sections using infrared scanning technology
Samantha L. Eaton et al.
JOURNAL OF ANATOMY (2016)
Adeno-Associated Virus-Based Gene Therapy for CNS Diseases
Michael Hocquemiller et al.
HUMAN GENE THERAPY (2016)
Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency
Melissa P. Wasserstein et al.
MOLECULAR GENETICS AND METABOLISM (2015)
AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease
Martin L. Katz et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A
E. Gabande-Rodriguez et al.
CELL DEATH AND DIFFERENTIATION (2014)
Pharmacological reversion of sphingomyelin-induced dendritic spine anomalies in a Niemann Pick disease type A mouse model
Ana I. Arroyo et al.
EMBO MOLECULAR MEDICINE (2014)
AAV9-mediated Expression of a Non-self Protein in Nonhuman Primate Central Nervous System Triggers Widespread Neuroinflammation Driven by Antigen-presenting Cell Transduction
Lluis Samaranch et al.
MOLECULAR THERAPY (2014)
Strong Cortical and Spinal Cord Transduction After AAV7 and AAV9 Delivery into the Cerebrospinal Fluid of Nonhuman Primates
Lluis Samaranch et al.
HUMAN GENE THERAPY (2013)
Safety Study of Adeno-Associated Virus Serotype 2-Mediated Human Acid Sphingomyelinase Expression in the Nonhuman Primate Brain
Ernesto A. Salegio et al.
HUMAN GENE THERAPY (2012)
Adeno-Associated Virus Serotype 9 Transduction in the Central Nervous System of Nonhuman Primates
Lluis Samaranch et al.
HUMAN GENE THERAPY (2012)
Merits of Combination Cortical, Subcortical, and Cerebellar Injections for the Treatment of Niemann-Pick Disease Type A
Jie Bu et al.
MOLECULAR THERAPY (2012)
Distribution of acid sphingomyelinase in rodent and non-human primate brain after intracerebroventricular infusion
Robin J. Ziegler et al.
EXPERIMENTAL NEUROLOGY (2011)
Brain pathology in Niemann Pick disease type A: insights from the acid sphingomyelinase knockout mice
Maria Dolores Ledesma et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates
Steven J. Gray et al.
MOLECULAR THERAPY (2011)
Magnetic Resonance Imaging-Guided Delivery of Adeno-Associated Virus Type 2 to the Primate Brain for the Treatment of Lysosomal Storage Disorders
E. Aguilar Salegio et al.
HUMAN GENE THERAPY (2010)
Caffeine and an adenosine A(2A) receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life
Giana P. Cognato et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease
James C. Dodge et al.
EXPERIMENTAL NEUROLOGY (2009)
Subcellular Origin of Sphingosine 1-Phosphate Is Essential for Its Toxic Effect in Lyase-deficient Neurons
Nadine Hagen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A Simplified Baculovirus-AAV Expression Vector System Coupled With One-step Affinity Purification Yields High-titer rAAV Stocks From Insect Cells
Richard H. Smith et al.
MOLECULAR THERAPY (2009)
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2009)
Synaptic Vesicle Docking: Sphingosine Regulates Syntaxin1 Interaction with Munc18
Paola G. Camoletto et al.
PLOS ONE (2009)
Neuropathology of the acid sphingomyelinase knockout mouse model of Niemann-Pick A disease including structure-function studies associated with cerebellar Purkinje cell degeneration
Shannon L. Macauley et al.
EXPERIMENTAL NEUROLOGY (2008)
Anomalous surface distribution of glycosyl phosphatidyl inositol-anchored proteins in neurons lacking acid sphingomyelinase
Cristian Galvan et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis
Volker Teichgraeber et al.
NATURE MEDICINE (2008)
Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium
Emyr Lloyd-Evans et al.
NATURE MEDICINE (2008)
The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease
E. H. Schuchman
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Combination brain and systemic injections of AAV provide maximal functional and survival benefits in the Niemann-Pick mouse
Marco A. Passini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine
MR Hojjati et al.
JOURNAL OF LIPID RESEARCH (2006)
Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease
JC Dodge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors
GM Liu et al.
JOURNAL OF NEUROSCIENCE (2005)
AAV8-Mediated hepatic expression of acid sphingomyelinase corrects the metabolic defect in the visceral organs of a mouse model of Niemann-Pick disease
CM Barbon et al.
MOLECULAR THERAPY (2005)
AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease
MA Passini et al.
MOLECULAR THERAPY (2005)
Striatal delivery of rAAV-hAADC to rats with preexisting immunity to AAV
LM Sanftner et al.
MOLECULAR THERAPY (2004)
Lipid abnormalities in children with types A and B Niemann Pick disease
MM McGovern et al.
JOURNAL OF PEDIATRICS (2004)
A fluorescence-based, high-performance liquid chromatographic assay to determine acid sphingomyelinase activity and diagnose types A and B Niemann-Pick disease
XX He et al.
ANALYTICAL BIOCHEMISTRY (2003)
Clustering of CD40 ligand is required to form a functional contact with CD40
H Grassmé et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Infusion of recombinant human acid sphingomyelinase into Niemann-Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology
SRP Miranda et al.
FASEB JOURNAL (2000)
Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann-Pick disease
SRP Miranda et al.
GENE THERAPY (2000)
Share Paper
